Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Alpelisib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hyperglycemia 2 Hereditary Sensory and Autonomic Neuropathies 2 Endometrial Neoplasms 2 Vascular Malformations 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Genetic Diseases, Inborn 1 Fallopian Tube Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 23 Cisplatin 20 Carboplatin 13 Paclitaxel 10 Radiotherapy 8 Radiotherapy, Intensity-Modulated 7 Docetaxel 7 cemiplimab 6 Nivolumab 6 Fluorouracil 6 Radiation 5 durvalumab 4 Drug Therapy 4 Taxes 3 Surveys and Questionnaires 3 Cetuximab 3 Blood Specimen Collection 3 toripalimab 2 atezolizumab 2 alpha-2'-deoxythioguanosine 2 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Petrolatum 2 Pemetrexed 2 vistusertib 1 talazoparib 1 sitravatinib 1 regorafenib 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡